Jim Tananbaum is the founder of Foresite Capital. He set up the private healthcare firm in 2011. Foresite Capital seeks to identify emerging healthcare leaders and provide them with adequate capital, information, and networks.
Prior to forming the company, Tananbaum had co-established two leading biopharmaceutical firms and two healthcare investment entities. He is credited for incorporating GelTex Pharmaceuticals. This corporation introduced two drugs to the market using less than $80 million. The company was sold in 1998 for $1.6 billion. At the time, its leading drug, Renagel, had a yearly revenue run rate of more than $200 million. Presently, Renagel (Renzela) is estimated to generate nearly $1 billion in annual revenue.
In addition, Tananbaum co-established and served as the CEO of Theravance, Inc. Through a joint venture, the firm is a shareholder of GSK’s respiratory franchise. Under Jim’s leadership, the company was able to successfully complete a spin-off that resulted in the formation of Theravance Biopharma, Inc. The two firms have a joint market capitalization of $3.2 billion. You can visit Ideamensch to know more.
Jim is a founding partner of Prospect Venture Partners II and III. Previously, he was a partner at Sierra Ventures. Jim played a pivotal role in creating its healthcare services investment practice. Additionally, he has rendered his services to many investments, including Amerigroup, Jazz Pharmaceuticals, Amira Pharmaceuticals, and Healtheon. Jim incorporated Foresite Capital with the objective of combining his vast experience and knowledge to form an original investment plan.
Jim notes that the idea of creating Foresite Capital came from his extensive experience as a healthcare entrepreneur and investment strategist for over two decades. Within this period, Jim was able to identify vital success factors that would facilitate the growth of many entrepreneurs and firms. According to him, the name Foresite means to comprehend and harness healthcare’s future. He contends that idea of starting the venture came from recognizing that innovative healthcare solutions require more time and resources than most businesspersons appreciate. You can visit Bloomberg for more info.
About Jim Tananbaum
He is the chief executive officer of Foresite Capital Management. Jim Tananbaum has been behind the success of over 21 healthcare firms, including Amerigroup. He has served on the advisory boards and visiting committees of Yale School of Engineering and Harvard-MIT HST program.
Jim Tananbaum earned his MD from the renowned Harvard Medical School. In addition, the shrewd entrepreneur holds an MBA from the prestigious Harvard Business School. Tananbaum graduated with a BS degree and B.S.E.E. from the esteemed Yale University.
Jim Tananbaum Facebook: https://www.facebook.com/public/Jim-Tananbaum